| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| adrenalinbitartrat 5 µg + lidocainhydrochlorid 10 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate + lidocaine hydrochloride 20mcg/20mg inj |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
|
| adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 1 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
|
| adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 4 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
|
| adrenalinbitartrat 1 % + pilocarpinhydrochlorid 6 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
|
| adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 2 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
|
| adrenalinbitartrat + pilocarpinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
|
| adrenalinbitartrat 0,01 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
|
| adrenalinbitartrat 0,1 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
|
| bupivacainhydrochlorid 2,5 mg + adrenalinbitartrat 5 µg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
|
| Epinephrine acid tartrate 0.01% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
|
| Epinephrine acid tartrate 0.1% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine (as epinephrine bitartrate) 5 milligram/5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine (as epinephrine bitartrate) 5 milligram/5 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/10 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline (as adrenaline acid tartrate) 100 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
2 |
| Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
2 |
| Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
2 |
| Adrenaline (as adrenaline acid tartrate) 500 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
2 |
| Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely epinephrine (as epinephrine bitartrate) 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epinephrine bitartrate (substance) |
Inferred relationship |
Some |
1 |
FHIR